Explore the complete list of API intermediates and key starting materials (KSMs) manufactured by Kimia Biosciences Ltd. Trusted global supplier with verified product lists, certifications, and compliance details through apicule’s global sourcing platform.
Country: India
API Intermediate Supplier Description: Kimia Biosciences Ltd. is an Indian pharmaceutical company incorporated in 1993 (formerly known as Laurel Organics Ltd.), headquartered in New Delhi with its primary WHO-GMP certified manufacturing operations based in Gurugram, Haryana. Under the executive leadership of Mr. Sameer Goel, the company functions as a research-driven manufacturer of Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), and drug intermediates. Kimia Biosciences focuses extensively on lifestyle disease management and high-potential therapeutic segments, maintaining a prominent commercial catalog that includes anti-diabetics (such as Dapagliflozin and Empagliflozin), anti-coagulants (such as Apixaban and Rivaroxaban), gastrointestinal agents, and anti-hypertensives. Backed by a strong R&D division, the company caters to both the domestic Indian market and global generic supply chains via dedicated Contract Development and Manufacturing Organisation (CDMO) services. - Show More
